190 related articles for article (PubMed ID: 29479836)
1. Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides.
Wolfe JM; Fadzen CM; Holden RL; Yao M; Hanson GJ; Pentelute BL
Angew Chem Int Ed Engl; 2018 Apr; 57(17):4756-4759. PubMed ID: 29479836
[TBL] [Abstract][Full Text] [Related]
2. Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy.
Fadzen CM; Holden RL; Wolfe JM; Choo ZN; Schissel CK; Yao M; Hanson GJ; Pentelute BL
Biochemistry; 2019 Sep; 58(38):3980-3989. PubMed ID: 31450889
[TBL] [Abstract][Full Text] [Related]
3. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
4. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
Takada H; Tsuchiya K; Demizu Y
Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.
Haque US; Yokota T
Cells; 2023 Oct; 12(19):. PubMed ID: 37830609
[TBL] [Abstract][Full Text] [Related]
6. Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide.
Yeoh YQ; Amin A; Cuic B; Tomas D; Turner BJ; Shabanpoor F
Biomed Pharmacother; 2024 Jun; 175():116737. PubMed ID: 38749176
[TBL] [Abstract][Full Text] [Related]
7. Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice.
Wang M; Wu B; Tucker JD; Lu P; Lu Q
Int J Nanomedicine; 2015; 10():5635-46. PubMed ID: 26366082
[TBL] [Abstract][Full Text] [Related]
8. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
10. Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides.
Burki U; Keane J; Blain A; O'Donovan L; Gait MJ; Laval SH; Straub V
Nucleic Acid Ther; 2015 Oct; 25(5):275-84. PubMed ID: 26176274
[TBL] [Abstract][Full Text] [Related]
11. Cell-Penetrating d-Peptides Retain Antisense Morpholino Oligomer Delivery Activity.
Schissel CK; Farquhar CE; Malmberg AB; Loas A; Pentelute BL
ACS Bio Med Chem Au; 2022 Apr; 2(2):150-160. PubMed ID: 37101743
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective uptake of cell-penetrating peptides is conserved in antisense oligonucleotide polyplexes.
Favretto ME; Brock R
Small; 2015 Mar; 11(12):1414-7. PubMed ID: 25382156
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy.
Betts CA; Wood MJ
Curr Pharm Des; 2013; 19(16):2948-62. PubMed ID: 23140454
[TBL] [Abstract][Full Text] [Related]
14. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy.
Hammond SM; Abendroth F; Gait MJ; Wood MJA
Methods Mol Biol; 2019; 2036():221-236. PubMed ID: 31410800
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
[TBL] [Abstract][Full Text] [Related]
17. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
Moulton HM; Hase MC; Smith KM; Iversen PL
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):31-43. PubMed ID: 12691534
[TBL] [Abstract][Full Text] [Related]
18. Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers.
Moulton HM
Methods Mol Biol; 2012; 867():407-14. PubMed ID: 22454076
[TBL] [Abstract][Full Text] [Related]
20. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]